We offer the legal and technical experience and global awareness needed to understand the opportunities offered and challenges presented to these industries.
Our Life Sciences group consists of a multidisciplinary team of lawyers with extensive industry knowledge and resources. The group comprises lawyers from across the firm’s practices. These lawyers are experienced in dealing with the issues affecting the life sciences industries globally, including: transactions, intellectual property (IP), dispute resolution, antitrust and competition, risk management, investigations and compliance, government and global trade, tax and transfer pricing, and regulatory and environmental matters.
At Mayer Brown, we have a long history of providing clients in these industry sectors with practical and effective legal support. Our clients range from start-ups to some of the largest life sciences companies in the world.
We also represent a significant number of regional, national and global banks, investment banks and other investors in capital markets and structured finance transactions relating to the life sciences industries.
Our geographic reach and on-the-ground presence in most of the world’s key business and finance centers allow us to assist our clients in structuring and coordinating cross-border transactions and other transnational legal matters. Our in-depth experience, gained by working across business areas and issues with life sciences companies and networking with leading industry organizations, provides our lawyers with the necessary insights for handling the legal and regulatory challenges facing these industries.
Our Life Sciences practice provides advice on the full range of issues, including:
- Intellectual Property
- Hatch-Waxman Counseling & Litigation
- Dispute Resolution
- FDA Regulatory
- Antitrust and Competition
- Risk Management, Investigations and Compliance
- Government and Global Trade
- Tax and Transfer Pricing
- Regulatory and Environmental
Mayer Brown is a leading provider of legal services to a broad range of participants in the global pharmaceuticals, biotech and medical device industries.